Xenon Pharmaceuticals XENE Q1 2026 earnings
Reported May 7, 2026 · After market close
Revenue-
EPS-$1.17In line
EPS estimate-$1.17
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$1.7M
EPS estimate-$1.16
Financials
Q1 2026Valuation & ratios
Versus estimates
Ask the moment Xenon Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Xenon Pharmaceuticals report Q1 2026 earnings?
- Xenon Pharmaceuticals (XENE) reported Q1 2026 earnings on May 7, 2026 after market close.
- What were Xenon Pharmaceuticals's Q1 2026 revenue and EPS?
- Xenon Pharmaceuticals reported revenue of - and eps of $-1.17 for Q1 2026.
- Did Xenon Pharmaceuticals beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-1.17 by $0.00.
- How did Xenon Pharmaceuticals's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 100.0% from $7.5M a year earlier and eps declined 41.0% from $-0.83.
- Where can I find Xenon Pharmaceuticals's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-211843) and the 10-Q periodic report (0001193125-26-212153) directly on SEC EDGAR. The filing index links above go to sec.gov.